Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steroid Refractory Acute Graft Versus Host Disease”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Not applicableLooking for participantsNCT06321198
What this trial is testing

A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD

Who this might be right for
Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)
Anhui Provincial Hospital 12
Testing effectiveness (Phase 2)Study completedNCT02997280
What this trial is testing

Ruxolitinib for Steroid-refractory GVHD

Who this might be right for
Graft Vs Host Disease
St. Petersburg State Pavlov Medical University 75
Not applicableUnknownNCT05112263
What this trial is testing

Tofacitinib Versus Cyclosporine for Steroid Refractory Acute Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Post Graduate Institute of Medical Education and Research, Chandigarh 96
Large-scale testing (Phase 3)UnknownNCT04289103
What this trial is testing

Evaluation of EFficacy and SaFEty of Leukotac (Inolimomab) in Pediatric Patients With SR-aGvHD

Who this might be right for
Steroid Refractory GVHD
ElsaLys Biotech 65
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06075225
What this trial is testing

MAP-guided Preemptive Therapy of aGvHD by Ruxolitinib

Who this might be right for
GVHDAcute Stem Cell Transplant Complications
Sichuan University 62
Testing effectiveness (Phase 2)Ended earlyNCT05415410
What this trial is testing

Proof-of-concept Trial of Apraglutide in Acute Graft Versus Host Disease (aGVHD)

Who this might be right for
GVHD
VectivBio AG 31
Post-approval studies (Phase 4)Study completedNCT02770040
What this trial is testing

Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Austin Health 138
Large-scale testing (Phase 3)Study completedNCT01442233
What this trial is testing

Plasma Exchanges in Multiple Sclerosis (MS) Relapses

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Acute Relapsing
University Hospital, Bordeaux 38
Not applicableStudy completedNCT04687332
What this trial is testing

IA or PE - What is the Best Treatment Option of Steroid Refractory Neurological Autoimmune Diseases

Who this might be right for
Neurological Autoimmune Diseases
University Medical Center Mainz 32
Early research (Phase 1)Looking for participantsNCT06750133
What this trial is testing

Universal CNK-UT Therapy for Refractory aGVHD

Who this might be right for
Acute Graft-versus-Host Disease
First Affiliated Hospital of Zhejiang University 23
Testing effectiveness (Phase 2)Study completedNCT00827398
What this trial is testing

Treatment of Steroid Resistant GVHD by Infusion MSC

Who this might be right for
Graft-versus-host-disease
N.M. Wulffraat 50
Not applicableNo Longer AvailableNCT03172455
What this trial is testing

Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Acute-graft-versus-host DiseaseSteroid Refractory Acute Graft Versus Host DiseaseGraft-versus-host-disease+5 more
Impatients N.V. trading as myTomorrows
Large-scale testing (Phase 3)Not Yet RecruitingNCT07568535
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trial of Remestemcel-L-rknd Added to Ruxolitinib for Grade III-IV Steroid-Refractory Acute Graft-Versus-Host Disease

Who this might be right for
GVHD - Graft-Versus-Host Disease
Mesoblast, Ltd. 180
Testing effectiveness (Phase 2)Ended earlyNCT01453140
What this trial is testing

In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus

Who this might be right for
Graft Versus Host Disease
Hackensack Meridian Health 3
Testing effectiveness (Phase 2)Study completedNCT02027805
What this trial is testing

Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD

Who this might be right for
Graft vs Host Disease
Xenikos 20
Not applicableLooking for participantsNCT07184853
What this trial is testing

Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHD

Who this might be right for
Graft vs Host Disease
First Affiliated Hospital of Zhejiang University 122
Large-scale testing (Phase 3)Ended earlyNCT02524847
What this trial is testing

Methoxsalen and Extracorporeal Photopheresis (ECP) for the Treatment of Pediatric Participants With Steroid Refractory Acute Graft Versus Host Disease

Who this might be right for
Steroid Refractory Acute Graft Versus Host Disease
Therakos, Inc., a Mallinckrodt Company 29
Testing effectiveness (Phase 2)WithdrawnNCT02694770
What this trial is testing

A Study Evaluating the Efficacy and Safety of Neihulizumab vs "Conventional Treatment" to Treat Sr-aGvHD

Who this might be right for
Steroid-refractory aGvHD Subsequent to Allogeneic Hematopoietic Cell Transplantation
AbGenomics B.V Taiwan Branch
Testing effectiveness (Phase 2)Ended earlyNCT01903473
What this trial is testing

Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)

Who this might be right for
Chronic Graft-Versus-Host DiseaseAcute Graft-Versus-Host DiseaseSteroid Refractory Graft-Versus-Host Disease
University of Liege 19
Testing effectiveness (Phase 2)Study completedNCT02953678
What this trial is testing

Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 71
Next Page